QuickView for negative regulation of intracellular estrogen receptor signaling pathway (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
5. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens

There were no matches for negative regulation of intracellular estrogen receptor signaling pathway

1. Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
2. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
3. IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
4. Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospecti…